Drug Profile
Research programme: peptide antibacterials - SpiderBiotech
Alternative Names: Peptide antibiotics - SpiderBiotech; SB-006; SB006-based antimicrobial peptides - SpiderBiotech; Tetrabranched antibacterial peptides - SpiderBiotech/NeED PharmaceuticalsLatest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator SpiderBiotech
- Class Peptides
- Mechanism of Action
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Gram-negative infections
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Gram-negative-infections in Italy
- 22 Apr 2008 Antimicrobial & pharmacodynamic data from a preclinical trial in Gram-negative infections presented at the 18th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID-2008)
- 31 Dec 2005 Preclinical trials in Gram-negative infections in Italy (unspecified route)